Inventor
MCCALL JOHN
US23 patents
⚠️ This page may combine multiple inventors who share the name “MCCALL JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VETTORE LLC
7 patentsUS11292767B2Apr 5, 2022
Heterocyclic inhibitors of MCT4
VETTORE LLC5 citations82
US11155522B2Oct 26, 2021
MCT4 inhibitors for treating disease
VETTORE LLC4 citations82
US10214492B2Feb 26, 2019
Heterocyclic inhibitors of MCT4
VETTORE LLC6 citations82
US10202350B2Feb 12, 2019
MCT4 inhibitors for treating disease
VETTORE LLC6 citations82
US12187682B2Jan 7, 2025
MCT4 inhibitors for treating disease
VETTORE LLC1 citations73
US11724989B2Aug 15, 2023
MCT4 inhibitors for treating disease
VETTORE LLC2 citations71
US12492171B2Dec 9, 2025
Heterocyclic inhibitors of MCT4
VETTORE LLC0 citations60
LINDSEY MFG CO
4 patentsUS10983173B2Apr 20, 2021
Active current monitor
LINDSEY MFG CO2 citations70
US10855107B2Dec 1, 2020
System and method for generating a transmission line reliability rating
LINDSEY MFG CO4 citations64
US11443155B2Sep 13, 2022
Insulator leakage current detector and method of detecting insulator leakage current
LINDSEY MFG CO0 citations62
US11680993B2Jun 20, 2023
Active current monitor
LINDSEY MFG CO0 citations60
REVERAGEN BIOPHARMA INC
3 patentsUS11382922B2Jul 12, 2022
Aqueous oral pharmaceutical suspension compositions
REVERAGEN BIOPHARMA INC4 citations82
US12201639B2Jan 21, 2025
Aqueous oral pharmaceutical suspension compositions
REVERAGEN BIOPHARMA INC1 citations73
US11471471B2Oct 18, 2022
Aqueous oral pharmaceutical suspension compositions
REVERAGEN BIOPHARMA INC3 citations71
BIOENERGENIX LLC
3 patentsUS10392389B2Aug 27, 2019
Heterocyclic compounds for the inhibition of PASK
BIOENERGENIX LLC2 citations72
US9278973B2Mar 8, 2016
Heterocyclic compounds for the inhibition of PASK
BIOENERGENIX LLC3 citations72
US11191765B2Dec 7, 2021
Heterocyclic compounds for the inhibition of PASK
BIOENERGENIX LLC0 citations62